152 related articles for article (PubMed ID: 26069486)
1. Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model.
Perumal V; Banerjee S; Das S; Sen RK; Mandal M
Cancer Nanotechnol; 2011; 2(1-6):67-79. PubMed ID: 26069486
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
[TBL] [Abstract][Full Text] [Related]
3. Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation.
Matbou Riahi M; Sahebkar A; Sadri K; Nikoofal-Sahlabadi S; Jaafari MR
Int J Pharm; 2018 Apr; 540(1-2):89-97. PubMed ID: 29371019
[TBL] [Abstract][Full Text] [Related]
4. The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer.
Venkatesan P; Puvvada N; Dash R; Prashanth Kumar BN; Sarkar D; Azab B; Pathak A; Kundu SC; Fisher PB; Mandal M
Biomaterials; 2011 May; 32(15):3794-806. PubMed ID: 21392822
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib.
Moghimipour E; Salami A; Monjezi M
Jundishapur J Nat Pharm Prod; 2015 Feb; 10(1):e17653. PubMed ID: 27747190
[TBL] [Abstract][Full Text] [Related]
6. Preventative effect of celecoxib in dimethylbenz[a]anthracene-induced ovarian cancer in rats.
Shao Z; Wen Q; Zhu T; Jiang W; Kang Y; Xu C; Wang S
Arch Gynecol Obstet; 2018 Nov; 298(5):981-989. PubMed ID: 30242499
[TBL] [Abstract][Full Text] [Related]
7. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells.
Limasale YD; Tezcaner A; Özen C; Keskin D; Banerjee S
Int J Pharm; 2015 Feb; 479(2):364-73. PubMed ID: 25595386
[TBL] [Abstract][Full Text] [Related]
9. Folic acid-modified liposomal drug delivery strategy for tumor targeting of 5-fluorouracil.
Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Dorkoosh FA; Handali S
Eur J Pharm Sci; 2018 Mar; 114():166-174. PubMed ID: 29247686
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Samy RP; Gopalakrishnakone P; Ignacimuthu S
Chem Biol Interact; 2006 Dec; 164(1-2):1-14. PubMed ID: 17064676
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.
Jang TJ; Jung HG; Jung KH; O MK
Int J Exp Pathol; 2002 Aug; 83(4):173-82. PubMed ID: 12485462
[TBL] [Abstract][Full Text] [Related]
12. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
13. Effect of AEE788 and/or Celecoxib on colon cancer cell morphology using advanced microscopic techniques.
Venkatesan P; Das S; Krishnan MM; Chakraborty C; Chaudhury K; Mandal M
Micron; 2010 Apr; 41(3):247-56. PubMed ID: 19945288
[TBL] [Abstract][Full Text] [Related]
14. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
[TBL] [Abstract][Full Text] [Related]
15. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
16. Utilization of thin film method for preparation of celecoxib loaded liposomes.
Moghimipour E; Handali S
Adv Pharm Bull; 2012; 2(1):93-8. PubMed ID: 24312776
[TBL] [Abstract][Full Text] [Related]
17. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Ahmed KS; Shan X; Mao J; Qiu L; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
[TBL] [Abstract][Full Text] [Related]
18. Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity.
Shrivastava R; Trivedi S; Singh PK; Asif M; Chourasia MK; Khanna A; Bhadauria S
Biochem Biophys Res Commun; 2018 Sep; 503(2):677-683. PubMed ID: 29908185
[TBL] [Abstract][Full Text] [Related]
19. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effects of nonsteroidal anti-inflammatory drugs on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
Kanwar SS; Vaiphei K; Nehru B; Sanyal SN
Toxicol Mech Methods; 2007; 17(4):197-204. PubMed ID: 20020969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
